Connect Biopharma Holdings Limited (CNTB)
NASDAQ·Healthcare·Biotechnology
$2.19
+9.80%
Mkt Cap $148.14M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$6.33
Range $4.00 – $9.00
Implied Upside
+189.7%
Consensus $6.33 vs current $2.19